EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of COVID-19 on Survival and Relapse in Pediatric Cancer ‎Patients

Seyed Reza Abdipour Mehrian, Parisa Pishdad, Zahra Mansouri, Maryam Sharifi, Elahe Meftah, Mohammad Farhadi, Adrina Habibzadeh, Ali Amanati

Archives of Pediatric Infectious Diseases · 08.10.2025 · 14 (4)

DOI: 10.5812/apid-160947 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Pediatric Infectious Diseases, online erschienen am 08.10.2025. Verfasst von Seyed Reza Abdipour Mehrian und 7 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) significantly affects vulnerable populations, including pediatric patients with malignancies.

Objectives

This study aimed to address knowledge gaps regarding COVID-19 in pediatric oncology patients by investigating clinical outcomes, complications, and risk factors.

Methods

In this retrospective cohort study, data from 9,171 hospitalized pediatric patients, including 146 COVID-19-positive patients, were analyzed. Clinical, demographic, and radiological data were collected, and statistical analyses were conducted using STATA version 17.

Results

During five national peaks, 9,171 pediatric patients were admitted to our tertiary oncology teaching hospital. Of these, 1,944 patients were tested for SARS-CoV-2 infection using polymerase chain reaction (PCR) assays, with 146 patients (7.5%) testing positive. Acute lymphoblastic leukemia (ALL) was the most prevalent malignancy (41%) in this study. The common presenting symptoms included fever (48%), generalized weakness (15%), and cough (15%). Radiological evaluation revealed no abnormalities in 38.58% of chest radiographs and 42.86% of computed tomography (CT) scans, whereas severe findings were noted in 11.02% and 7.14%, respectively. In this study, only 0.7% of COVID-positive patients required intensive care unit (ICU) admission, and 1.54% required mechanical ventilation. Among the COVID-positive patients, 22 (15%) died, with over 30% of these deaths occurring 10 days post-diagnosis, as indicated by the Kaplan-Meier survival estimate. Additionally, seven COVID-19-positive patients had a relapse of malignancy within 16 weeks of their COVID-19 diagnosis. The average time to relapse following SARS-CoV-2 infection was estimated to be 245.85 ± 213.24 days. Disease relapse [adjusted odds ratio (aOR): 2.09, P = 0.026], age < 12 months (aOR: 2.62, P = 0.010), and neuroblastoma diagnosis (aOR: 3.38, P = 0.005) were significantly associated with increased mortality in the multivariate analysis.

Conclusions

Although a 15% mortality rate was observed among pediatric oncology patients with COVID-19, multivariate analysis did not demonstrate a statistically significant association between COVID-19 infection and an increased risk of relapse or mortality after adjusting for confounding factors. These findings suggest that, despite the observed mortality, COVID-19 infection was not an independent predictor of adverse outcomes in this population.

Zitieren

APA

Mehrian, S. R. A., Pishdad, P., Mansouri, Z., Sharifi, M., Meftah, E., Farhadi, M., Habibzadeh, A., & Amanati, A. (2025). Impact of COVID-19 on Survival and Relapse in Pediatric Cancer ‎Patients. Archives of Pediatric Infectious Diseases, 14(4). https://doi.org/10.5812/apid-160947

Vancouver

Mehrian SRA, Pishdad P, Mansouri Z, Sharifi M, Meftah E, Farhadi M, et al. Impact of COVID-19 on Survival and Relapse in Pediatric Cancer ‎Patients. Archives of Pediatric Infectious Diseases. 2025;14(4). doi:10.5812/apid-160947

BibTeX
@article{Mehrian2025,
  author = {Mehrian, Seyed Reza Abdipour and Pishdad, Parisa and Mansouri, Zahra and Sharifi, Maryam and Meftah, Elahe and Farhadi, Mohammad and Habibzadeh, Adrina and Amanati, Ali},
  title = {Impact of COVID-19 on Survival and Relapse in Pediatric Cancer ‎Patients},
  journal = {Archives of Pediatric Infectious Diseases},
  year = {2025},
  volume = {14},
  number = {4},
  doi = {10.5812/apid-160947}
}
Kostenlos starten →